Peripheral Artery Disease ManagementCardiovascular Health and Disease PreventionDiagnosis and Treatment of Venous DiseasesDiabetic Foot Ulcer Assessment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
We prepare their research opportunity report and reach out personally to introduce you — their contact details stay private.
Their published papers and profiles list institutional contact details.
This profile was built automatically from public publication records and has not yet been claimed by the researcher.
Research opportunities
Study designs adjacent to this body of work — each grounded in the published record and scoped so a trainee could run it.
Claim your researcher profile
This profile was built from your public publication record — claim it to manage it.
What are the specific long-term treatment strategies required to mitigate the risk of developing chronic non-communicable diseases in children born to mothers with gestational diabetes mellitus?
Why this gap exists: While the retrieved literature consistently establishes that maternal gestational diabetes mellitus (GDM) increases the long-term risk of cardiometabolic diseases in offspring [1][2][3], it focuses primarily on pathogenesis and risk association rather than defining specific, evidence-based long-term treatment strategies for the children to mitigate these risks.
How do specific maternal microbiota profiles (gut, oral, or vaginal) during gestation correlate with the development of gestational diabetes mellitus (GDM) and subsequent long-term metabolic health in offspring?
Why this gap exists: While recent reviews [8] confirm GDM alters maternal gut microbiota and neonatal health, and older studies [0] note dysbiosis across maternal sites, the retrieved evidence lacks direct, longitudinal studies correlating specific gestational maternal microbiota profiles with the *long-term* metabolic health of offspring, leaving the core question unresolved.
Microbes in the Moonlight: How the Gut Microbiota Influences Sleep — arXiv preprint, 2025
How do specific policy frameworks regarding social protection and food systems in low-income countries moderate the projected increase in child wasting and maternal undernutrition caused by economic shocks like the COVID-19 pandemic?
Why this gap exists: While the retrieved literature confirms the projected increase in child wasting and maternal undernutrition due to COVID-19 disruptions [0] and explores general concepts of food system resilience [2] and social protection [3], no study directly quantifies how specific policy frameworks moderate these projected outcomes, leaving the core interaction unresolved.
How does the consumption of plant-based proteins, specifically those high in anti-nutritional factors like phytates and trypsin inhibitors, affect mineral bioavailability and growth outcomes in children relying on these proteins as primary staples?
Why this gap exists: While the retrieved papers confirm that anti-nutritional factors like phytates and trypsin inhibitors reduce mineral bioavailability [0, 2], they focus on general adult health or crop improvement [1, 6] and do not provide direct evidence on the specific growth outcomes in children relying on these proteins as primary staples.
What is the comparative efficacy of digital or telehealth lactation support versus traditional face-to-face peer support on breastfeeding exclusivity rates during pandemic-related social restrictions?
Why this gap exists: While Abstract [3] confirms the general effectiveness of digital health interventions on breastfeeding practices and Abstract [0] notes the cancellation of face-to-face peer support during the pandemic, the retrieved evidence does not contain a direct comparative study between digital/telehealth lactation support and traditional face-to-face peer support specifically regarding exclusivity rates during social restrictions.
What is the comparative efficacy and cost-effectiveness of the one-step 75g OGTT versus the two-step (50g GCT followed by 100g OGTT) diagnostic approach in preventing adverse maternal and neonatal outcomes?
Why this gap exists: While Abstract [7] compares diagnostic criteria and Abstract [4] compares 75g and 100g OGTTs, the retrieved evidence lacks direct, comparative studies on the cost-effectiveness and relative efficacy of the one-step versus two-step *approaches* in preventing adverse outcomes, leaving the specific question unresolved.